Viewing Study NCT05596266


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2025-12-26 @ 8:26 AM
Study NCT ID: NCT05596266
Status: UNKNOWN
Last Update Posted: 2022-10-27
First Post: 2022-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia
Sponsor: Xuanwu Hospital, Beijing
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module